NFE2L2 and adenocarcinoma: Moreover, epigallocatechin 3-gallate, that was previously described to activate Nrf2 counteracting kidney injury, at high doses induces apoptosis in adenocarcinoma cells, downregulating the constitutively active NRF2 and overcoming the acquired resistance [167].